Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Trav7d-3 Activators

Chemical activators of Trav7d-3 include a variety of compounds that initiate a cascade of intracellular events leading to the activation of this protein. Forskolin is known to directly activate adenylyl cyclase, which increases intracellular cAMP levels. The elevated cAMP then activates protein kinase A (PKA), which has the capacity to phosphorylate Trav7d-3, leading to its activation. Another activator, Phorbol 12-myristate 13-acetate (PMA), functions by activating protein kinase C (PKC). Activated PKC can phosphorylate Trav7d-3, enabling its functional activation. Ionomycin, by increasing intracellular calcium levels, can activate calmodulin-dependent kinases (CaMK), which can then phosphorylate and activate Trav7d-3.

Similarly, Dibutyryl-cAMP, a cAMP analog, can activate PKA, which in turn can lead to the phosphorylation and activation of Trav7d-3. Okadaic Acid and Calyculin A are both inhibitors of protein phosphatases 1 and 2A, which maintain Trav7d-3 in a phosphorylated and active state by preventing its dephosphorylation. Anisomycin activates the MAPK/ERK pathway, leading to Trav7d-3 activation through phosphorylation by ERK. Another cAMP analog, 8-Bromo-cAMP, activates PKA, which can phosphorylate and activate Trav7d-3. Chelerythrine, although a PKC inhibitor, under specific conditions can activate certain PKC isoforms, leading to the activation of Trav7d-3. Bisindolylmaleimide I, while selectively inhibiting PKC, can lead to the compensatory activation of alternative pathways that result in the activation of Trav7d-3. Staurosporine, despite being a broad-spectrum kinase inhibitor, can activate certain kinases through feedback loops, which can lead to Trav7d-3 activation. Lastly, (-)-Epigallocatechin Gallate (EGCG) inhibits specific phosphatases, which increases the phosphorylation and subsequent activation of proteins, potentially including Trav7d-3. Each of these chemicals, through their interaction with different cellular pathways and enzymes, ensures the phosphorylation and activation state of Trav7d-3 is achieved.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), which can then phosphorylate and activate Trav7d-3 as part of downstream signaling.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK), potentially leading to the phosphorylation and activation of Trav7d-3.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl-cAMP is a cAMP analog that activates PKA, and subsequently, PKA can phosphorylate and activate Trav7d-3.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic Acid inhibits protein phosphatases 1 and 2A, preventing dephosphorylation and maintaining Trav7d-3 in an activated phosphorylated state.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Calyculin A, similar to Okadaic Acid, inhibits protein phosphatases, leading to sustained phosphorylation and activation of Trav7d-3.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin activates the MAPK/ERK pathway, which could lead to the activation of Trav7d-3 through phosphorylation by ERK.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

8-Bromo-cAMP is a cell-permeable cAMP analog that specifically activates PKA, which could then phosphorylate and activate Trav7d-3.

Chelerythrine

34316-15-9sc-507380
100 mg
$540.00
(0)

Chelerythrine is a PKC inhibitor that can paradoxically activate certain PKC isoforms under specific conditions, potentially leading to Trav7d-3 activation.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Bisindolylmaleimide I selectively inhibits PKC, which can lead to compensatory activation of alternative pathways that activate Trav7d-3.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum kinase inhibitor that can inadvertently activate certain kinases through feedback loops, potentially leading to Trav7d-3 activation.